Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Electroencephalogram Changes Induced by Transcutaneous Electrical Acupoint Stimulation

NCT: NCT07819630 · RECRUITING

NCT IDNCT07819630
StatusRECRUITING
Start Date2026-10-31
Completion2027-03-30
SponsorBeijing Chao Yang Hospital (OTHER)
First posted
Last updated

Brief Summary

A total of 90 subjects underwent abdominal surgery under general anesthesia at Chaoyang Hospital in Beijing. The subjects were divided into a percutaneous acupoint electrical stimulation group and a control group. The subjects were selected for TEAS stimulation at the Neiguan, Hegu, and Zusanli acupoints on both sides, and EEG data were collected using a 32 lead EEG cap test throughout the entire process. During the experiment, changes in hemodynamic parameters (blood pressure, heart rate) and perioperative pain scores of the subjects will be recorded.

Frequently Asked Questions

What is Electroencephalogram Changes Induced by Transcutaneous Electrical Acupoint Stimulation?

Electroencephalogram Changes Induced by Transcutaneous Electrical Acupoint Stimulation is a clinical trial registered under NCT07819630. Current status: RECRUITING.

What is the status of NCT07819630?

The current status of NCT07819630 (Electroencephalogram Changes Induced by Transcutaneous Electrical Acupoint Stimulation) is: RECRUITING.

When did Electroencephalogram Changes Induced by Transcutaneous Electrical Acupoint Stimulation start?

Electroencephalogram Changes Induced by Transcutaneous Electrical Acupoint Stimulation started on 2026-10-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.